{"page_content": "21      KODIAK 2021 ESG REPORT BACK TO CONTENTS >>\nLooking Forward \nAs we think about the potential for building commercial operations, \nour focus will remain on quality and efficiency across long, complex \nsupply chains, and we will continue to partner with those who share \nour ESG commitment.\nWE BELIEVE IMPORTANT CHALLENGES, INCLUDING THOSE IMPACTING ESG ISSUES, WILL \nINCLUDE: \n\u2022 Sourcing and securing an ethical, high-quality drug product supply chain at commercial scale.\n\u2022 Transporting and distributing essential ingredients efficiently.\n\u2022 Minimizing impacts from waste, energy and water use while maintaining high quality. \nAS PART OF THE SOLUTION TO THESE EFFORTS, WE INTEND TO TAKE STEPS TOWARDS \nDEVELOPING THE FOLLOWING:\n\u2022  Supplier code of conduct to establish expectations of suppliers and manufacturers that  \nreflect our values. \n\u2022  Supplier sustainability program to formally align our ESG priorities with our suppliers and \nmanufacturers.\n\u2022  Partner diversity initiative to begin identifying and engaging with small and diverse  \nbusinesses capable of providing goods and services across our enterprise.", "metadata": {"source": "NASDAQ_KOD_2021.pdf", "page": 20, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}